Tag: large-cap
Ericsson Stock Analysis: Buy or Sell? Valuation, FCF Yield & Margins
Telefonaktiebolaget LM Ericsson (ERIC) is rated Hold because its cash generation is exceptionally strong, but operating margin remains at 0.0%. The stock looks inexpensive on P/E and price-to-book, yet choppy revenue and weak earnings growth keep the operating case from supporting a more aggressive view.
Boeing Stock Analysis: Buy or Sell? Valuation, Margins & Production
Boeing (BA) is rated Sell as its recovery still looks uneven and the stock trades at a rich multiple despite weak profitability. TTM EBITDA margin is -3.1% and debt remains heavy, leaving limited room for another execution slip.
Chipotle Mexican Grill Stock Analysis: Buy or Sell? Valuation & Margin
Chipotle Mexican Grill (CMG) is rated Hold because its sourcing moat and execution remain strong, but the stock already prices in more profit improvement than recent results support. TTM EV/Revenue of 4.0x and EV/EBITDA of 21.1x leave little room for disappointment as EPS growth slows.
Host Hotels & Resorts Stock Analysis: Buy or Sell? Valuation, FCF & Leverage
Host Hotels & Resorts (HST) is rated Hold as its cash-flow cushion and 10.5% FCF yield help support the equity. However, the stock already prices in a fair recovery, while leverage and hotel margin improvement remain the key debate.
Take-Two Interactive Stock Analysis: Buy or Sell? Valuation, Margins & GTA VI
Take-Two Interactive Software (TTWO) is rated Sell as the stock appears to price in a clean Grand Theft Auto VI launch while margins remain thin. Franchise concentration and platform dependence leave little room for execution missteps.
Cigna Group Stock Analysis: Buy or Sell? Valuation, Cash Flow & Margin
The Cigna Group (CI) is rated Hold as its durable cash generation offsets a post-divestiture earnings base that still needs to prove itself. The 9.0% FCF yield and 1.72x net debt to EBITDA support the stock, but margin improvement remains the key test.
Teva Pharmaceutical Stock Analysis: Buy or Sell? Valuation, Growth & Margins
Teva Pharmaceutical Industries Ltd. (TEVA) is rated Hold as the stock has already rerated on an earnings recovery, while revenue still faces generic pricing pressure. The business generates solid cash flow and strong EBITDA margins, but execution on branded growth and the AUSTEDO pricing reset remain key risks.
Newmont Corporation Stock Analysis: Buy or Sell? Valuation, Gold Prices & FCF
Newmont Corporation (NEM) is rated Hold as its stock already discounts a strong gold-price backdrop. The balance sheet is solid and free cash flow is strong, but downside grows if bullion normalizes and margins compress.
Omnicom Stock Analysis: Buy or Sell? Valuation, Leverage & Margins
Omnicom Group Inc. (OMC) is rated Hold as merger-driven scale is offset by thin margins and elevated debt. The 22.0% free cash flow yield supports the stock, but integration execution and client concentration remain key risks.
Pan American Silver Stock Analysis: Buy or Sell? Valuation & Margins
Pan American Silver (PAAS) is rated Hold as strong margins and a solid balance sheet are already reflected in the share price. Its 8.7x forward P/E and 7.0 PEG ratio leave limited room for disappointment if growth normalizes.